EPR Properties vs 22nd Century Group Inc — how do they compare? EPR Properties trades at $61.76 (market cap $4.60B), while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). The key difference: EPR Properties is far larger — about 3026.3× 22nd Century Group Inc's market cap, and EPR Properties pays a 6.19% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| EPR | XXII | |
|---|---|---|
Market Cap | $4.60B | $1.52M |
Sector | Real Estate | Technology |
52-Week High | $60.81 | $1.47K |
52-Week Low | $48.71 | $3.90 |
Enterprise Value | $7.66B | -$6.71M |
Dividend Yield | 6.19% | — |
Signals from Pluang's Aura AI — not financial advice
EPR Properties (EPR) trades at $61.80, up 3.8% over 24 hours, with a bullish technical signal from moving averages and a consensus analyst price target of $63.25. The REIT maintains strong profitability with a 39.93% net income margin and 10.68% ROE, supported by recent earnings beats and a strategic shift toward experiential assets like the $315 million Six Flags acquisition. Monthly dividends of $0.31 provide a steady income stream, with Q2 2026 earnings results due July 29, 2026.
Outlook remains positive due to high occupancy, dividend yield, and portfolio diversification, but risks include reliance on consumer spending and potential interest rate impacts. Analyst sentiment is mixed with a hold-heavy consensus, suggesting cautious optimism for income-focused investors amid stable fundamentals.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →